Patients' perceptions of topical treatments of actinic keratosis

被引:21
|
作者
Esmann, Solveig [1 ]
Jemec, Gregor B. E. [1 ]
机构
[1] Univ Copenhagen, Fac Hlth Sci, Roskilde Hosp, Dept Dermatol, DK-4000 Roskilde, Denmark
关键词
actinic keratosis; topical treatment; efficiency; pain; patient perspectives; interview; TREATMENT SATISFACTION; PHOTODYNAMIC THERAPY; 5-FLUOROURACIL; STIGMATIZATION; DERMATOLOGY; 0.5-PERCENT; EXPERIENCE; MANAGEMENT; PHYSICIANS; ADHERENCE;
D O I
10.3109/09546634.2012.757285
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objectives: In recent years, a number of topical treatments suitable for field-directed therapy of actinic keratosis (AK) have been developed. Non-surgical treatment of AK however requires strict adherence by patients. Patients' views on the different possible topical treatments are therefore relevant to the choice of treatment. The aim of the study was to disclose the "silent perspectives" by focusing on user experiences and individual perspectives on topical treatment. Materials and methods: Telephone interviews and face-to-face interviews were conducted with patients having had treatment with one or more of the following: imiquimod 5%, diclofenac sodium gel 3%, 5-fluorouracil (5-FU) cream 5% or photodynamic therapy. Results: 24 patients with AK were interviewed. Experiences of pain, discharging ulcers and efficiency of the treatment were of major importance. There was a general focus on appearance, social contacts and leisure time, although this appeared to be of lesser importance. Patients' perception of treatment instructions identified a risk of misunderstandings. Conclusion: Patients are primarily concerned with therapeutic efficiency. Pain and ulcers are central indicators, but appearance, social contacts and leisure time can also be considered as additional indicators of satisfaction. A firm focus on patient instruction is suggested.
引用
收藏
页码:375 / 379
页数:5
相关论文
共 50 条
  • [11] Evaluation of the costs of topical treatments for actinic keratosis based on lesion response and the affected area
    Calzavara-Pinton, Piergiacomo
    Zane, Cristina
    Arisi, Mariachiara
    Hamon, Pol-Antoine
    Tanova, Neda T.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2018, 153 (06): : 764 - 775
  • [12] Topical Immunotherapy for Actinic Keratosis and Field Cancerization
    Masferrer, Laura Bernal
    Cazana, Tamara Gracia
    Alonso, Isabel Bernad
    Alvarez-Salafranca, Marcial
    Blasco, Manuel Almenara
    Rentero, Maria Gallego
    de la Fuente, Angeles Juarranz
    Gilaberte, Yolanda
    CANCERS, 2024, 16 (06)
  • [13] Safety of topical interventions for the treatment of actinic keratosis
    Koch, Elias A. T.
    Wessely, Anja
    Steeb, Theresa
    Berking, Carola
    Heppt, Markus V.
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (07) : 801 - 814
  • [14] Topical therapies for skin cancer and actinic keratosis
    Haque, Tasnuva
    Rahman, Khondaker M.
    Thurston, David E.
    Hadgraft, Jonathan
    Lane, Majella E.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 : 279 - 289
  • [15] Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis
    Rowlands, Megan A.
    Giacometti, Joseph N.
    Servat, Javier
    Materin, Miguel A.
    Levin, Flora
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 33 (01): : E21 - E23
  • [16] Topical management of actinic keratosis and field cancerisation
    Stockfleth, E.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (04): : 459 - 462
  • [17] Frequency of procedural and medical treatments for actinic keratosis
    Ranpariya, Varun
    Muddasani, Suraj
    Feldman, Steven R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB194 - AB194
  • [18] Patient-reported adherence and persistence to topical treatments for actinic keratosis: a longitudinal diary study
    Erntoft, S.
    Norlin, J. M.
    Pollard, C.
    Diepgen, T. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (05) : 1094 - 1096
  • [19] Cost-Effectiveness Analysis of Topical Treatments for Actinic Keratosis in Italian National Health System
    Hyeraci, Mariafrancesca
    Pistore, Gianluca
    Ricci, Francesco
    Moro, Francesco
    Di Lella, Giovanni
    Dellambra, Elena
    Abeni, Damiano
    Fania, Luca
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [20] Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
    Gareth J. Thomas
    Colin A. Morton
    Dermatology and Therapy, 2017, 7 : 21 - 29